ID

16056

Beskrivning

Documentation part: Status of Treatment Bling & Study Conclusion A Randomised, Observer-blind, Multicentre, Non-inferiority, Comparative, Phase III Study of the Safety and Efficacy of Topical 1% SB-275833 Ointment, Applied Twice Daily for 5 Days, versus Topical 2% Sodium Fusidate Ointment Applied Three Times Daily for 7 Days in the Treatment of Adult and Paediatric Subjects with Impetigo. ClinicalTrials.gov Identifier: NCT00133874 Other Study ID Numbers: TOC100224 Responsible Party: GlaxoSmithKline

Nyckelord

Versioner (1)
  1. 2016-06-27 2016-06-27 -
Uppladdad den

27 juni 2016

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Status of Treatment Bling & Study Conclusion Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874

Engelsk

Status of Treatment Bling & Study Conclusion Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874

1 Formulär  
Status of Treatment Blind (BLIND)
Beskrivning

Status of Treatment Blind (BLIND)

Was the treatment blind broken during the study?
Beskrivning

If yes, complete the Adverse Event form and/or Investigational Product forms as appropriate

Datatyp

text

Alias
UMLS CUI [1]
C2347038
Date blind broken
Beskrivning

Date blind broken

Datatyp

date

Måttenheter
  • DDMONYYYY
Alias
UMLS CUI [1]
C0011008
DDMONYYYY
Reason blind broken
Beskrivning

Reason blind broken

Datatyp

text

Alias
UMLS CUI [1]
C0392360
If "Other", please specify:
Beskrivning

If

Datatyp

text

Alias
UMLS CUI [1,1]
C0392360
UMLS CUI [1,2]
C0205394
Study Conclusion (CONC)
Beskrivning

Study Conclusion (CONC)

Date of subject completion or date of subject withdrawal
Beskrivning

Date of subject completion or date of subject withdrawal

Datatyp

date

Alias
UMLS CUI [1]
C2983670
UMLS CUI [2,1]
C0011008
UMLS CUI [2,2]
C0422727
Was the subject withdrawn from the study?
Beskrivning

Was the subject withdrawn from the study?

Datatyp

text

Alias
UMLS CUI [1]
C0422727
If "Yes", select primary reason for withdrawal
Beskrivning

If "Yes", select primary reason for withdrawal

Datatyp

text

Alias
UMLS CUI [1,1]
C0392360
UMLS CUI [1,2]
C0422727
If "other", specify:
Beskrivning

If "other", specify:

Datatyp

text

Alias
UMLS CUI [1,1]
C0392360
UMLS CUI [1,2]
C0205394
Tillbaka till toppen

Similar models

Status of Treatment Bling & Study Conclusion Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
Status of Treatment Blind (BLIND)
Item
Was the treatment blind broken during the study?
text
C2347038 (UMLS CUI [1])
Was the treatment blind broken during the study?
Code List
Was the treatment blind broken during the study?
CL Item
No (N)
CL Item
Yes (Y)
Date blind broken
Item
Date blind broken
date
C0011008 (UMLS CUI [1])
Item
Reason blind broken
text
C0392360 (UMLS CUI [1])
Reason blind broken
Code List
Reason blind broken
CL Item
Medical emergency requiring identification of investigational product for further treatment (1)
CL Item
Other (2)
If
Item
If "Other", please specify:
text
C0392360 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Item Group
Study Conclusion (CONC)
Date of subject completion or date of subject withdrawal
Item
Date of subject completion or date of subject withdrawal
date
C2983670 (UMLS CUI [1])
C0011008 (UMLS CUI [2,1])
C0422727 (UMLS CUI [2,2])
Item
Was the subject withdrawn from the study?
text
C0422727 (UMLS CUI [1])
Was the subject withdrawn from the study?
Code List
Was the subject withdrawn from the study?
CL Item
No (N)
CL Item
Yes (Y)
Item
If "Yes", select primary reason for withdrawal
text
C0392360 (UMLS CUI [1,1])
C0422727 (UMLS CUI [1,2])
If "Yes", select primary reason for withdrawal
Code List
If "Yes", select primary reason for withdrawal
CL Item
Adverse event (1)
CL Item
Lost to follow-up (2)
CL Item
Protocol violation (3)
CL Item
Subject decided to withdraw from the study (4)
CL Item
Lack of efficacy (5)
CL Item
Sponsor terminated study (6)
CL Item
Disease progression (7)
CL Item
Other (OT)
If "other", specify:
Item
If "other", specify:
text
C0392360 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial